Stay Informed About Key Developments for Our Company

The Latest Updates as They Happen

As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies.

 

Subscribe To Our Latest Investor News

News Highlights
May 12, 2021
First quarter of 2021:

Bayer: successful start to 2021

READ MORE
May 11, 2021

Bayer presents expanded research and new approaches to advance cancer care at 2021 ASCO Annual Meeting

READ MORE
May 10, 2021

Bayer’s finerenone meets primary endpoint in Phase III FIGARO-DKD study

READ MORE
April 27, 2021
CEO Werner Baumann at the Annual Stockholders’ Meeting:

“We’re optimistic for the future”

Read more
AD HOC

Discover Bayer’s Latest Ad Hoc Releases

READ MORE
Explore All
11 - 20of about 617 News
11 - 20of about 617 News
February 24, 2021
Bayer to Divest Environmental Science Professional Business and Further Strengthen Leadership Team of Crop Science Division
READ MORE
February 09, 2021
Not intended for U.S. and UK Media
Bayer submits finerenone for marketing authorization in China for the treatment of chronic kidney disease in type 2 diabetes
READ MORE
February 08, 2021
Not intended for U.S. and UK Media
Bayer and Orion expand development program for darolutamide in prostate cancer
READ MORE
February 08, 2021
Not intended for U.S. and UK Media
New data presented at 2021 ASCO GU Cancers Symposium add to robustness of the overall survival benefit and favorable safety profile for Nubeqa™
READ MORE
February 03, 2021
Not intended for U.S. and UK Media
Bayer receives approval for Nubeqa™ in China for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC)
READ MORE
February 03, 2021
Bayer announces agreement with plaintiffs’ counsel on class plan
READ MORE
January 20, 2021
Not intended for U.S. and UK Media
U.S. FDA approves vericiguat for patients with symptomatic chronic heart failure
READ MORE
January 13, 2021
Not intended for U.S. and UK Media - Virtual Bayer Pharma Media Day:
Bayer transforms pharma business through breakthrough innovation in healthcare
READ MORE
January 12, 2021
Not intended for U.S. and UK Media
U.S. FDA grants Priority Review to New Drug Application for finerenone to treat patients with chronic kidney disease and type 2 diabetes
READ MORE
January 11, 2021
Accelerating the Transformation of Bayer:
Supervisory Board of Bayer AG appoints Sarena Lin to Board of Management as Chief Transformation and Talent Officer
READ MORE
11 - 20of about 617 News
11 - 20of about 617 News